ClinicalTrials.gov
public full text
Public Domain
A Double-blind, Double-dummy, Multicenter, Randomized Study of the Efficacy and Tolerability of Valdecoxib 40 mg Versus Rofecoxib 50 mg in Treating the Symptoms of Ankle Sprain
The study compares valdecoxib 40 mg once daily vs. rofecoxib 50 mg one daily in treating the signs and symptoms of acute first- or second-degree ankle sprain. The study also evaluated the disability status, tolerability and safety of these treatments.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Prediction Model for Chronic Ankle Instability#885711
- Assessment of Return to Work and Functional Results of French Military Personnel After Ankle Ligamentoplasty#981901
- Comparing ESWT Doses for Post-Stroke Ankle Spasticity Treatment#1060737
- A Multicenter Efficacy Study of a Diclofenac+Menthol Gel in Subjects With Ankle Sprain#803323
- Efficacy and Safety of Ibuprofen in Patients With Ankle Injuries#863052
Record · ID 811167
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive